The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Dissecting Specificity in the Janus Kinases: The Structures of JAK-Specific Inhibitors Complexed to the JAK1 and JAK2 Protein Tyrosine Kinase Domains
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
The PyMOL Molecular Graphics System
DeLano, W. L. (2002) · Medical Entomology and Zoology · Cited by 18,147
Refinement of Macromolecular Structures by the Maximum-Likelihood Method
Murshudov, G. N., Vagin, A. A., & Dodson, E. J. (1997) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444996012255 · Cited by 14,742
Kabsch, W. (1993) · Journal of Applied Crystallography · doi:10.1107/s0021889893005588 · Cited by 3,578
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
Baxter, E. J., Scott, L. M., Campbell, P. J., East, C., Fourouclas, N., Swanton, S., Vassiliou, G. S., Bench, A. J., Boyd, E. M., Curtin, N., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71142-9 · Cited by 3,548
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
James, C., Ugo, V., Le Couédic, J.-P., Staerk, J., Delhommeau, F., Lacout, C., Garçon, L., Raslova, H., Berger, R., Bennaceur-Griscelli, A., et al. (2005) · Nature · doi:10.1038/nature03546 · Cited by 3,544
Levine, R. L., Wadleigh, M., Cools, J., Ebert, B. L., Wernig, G., Huntly, B. J. P., Boggon, T. J., Wlodarska, I., Clark, J. J., Moore, S., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.03.023 · Cited by 2,993
Rodig, S. J., Meraz, M. A., White, J. M., Lampe, P. A., Riley, J. K., Arthur, C. D., King, K. L., Sheehan, K. C. F., Yin, L., Pennica, D., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81166-6 · Cited by 853
The protein tyrosine kinase JAK1 complements defects in interferon-α/β and -γ signal transduction
Müller, M., Briscoe, J., Laxton, C., Guschin, D., Ziemiecki, A., Silvennoinen, O., Harpur, A. G., Barbieri, G., Witthuhn, B. A., Schindler, C., et al. (1993) · Nature · doi:10.1038/366129a0 · Cited by 760
Self-citationPrevention of organ allograft rejection by a specific Janus kinase 3 inhibitor
Changelian, P. S., Flanagan, M. E., Ball, D. J., Kent, C. R., Magnuson, K. S., Martin, W. H., Rizzuti, B. J., Sawyer, P. S., Perry, B. D., Brissette, W. H., et al. (2003) · Science · doi:10.1126/science.1087061 · Cited by 607
Peeters, P., Raynaud, S. D., Cools, J., Wlodarska, I., Grosgeorge, J., Philip, P., Monpoux, F., Van Rompaey, L., Baens, M., Van den Berghe, H., et al. (1997) · Blood · doi:10.1182/blood.v90.7.2535 · Cited by 491
Two putative protein-tyrosine kinases identified by application of the polymerase chain reaction
Wilks, A. F. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.5.1603 · Cited by 424
Self-citationRegulation of the Jak2 Tyrosine Kinase by Its Pseudokinase Domain
Saharinen, P., Takaluoma, K., & Silvennoinen, O. (2000) · Molecular and Cellular Biology · doi:10.1128/.20.10.3387-3395.2000 · Cited by 365
Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia
Flex, E., Petrangeli, V., Stella, L., Chiaretti, S., Hornakova, T., Knoops, L., Ariola, C., Fodale, V., Clappier, E., Paoloni, F., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072182 · Cited by 334
Signal transducer and activator of transcription proteins in leukemias
Benekli, M., Baer, M. R., Baumann, H., & Wetzler, M. (2003) · Blood · doi:10.1182/blood-2002-04-1204 · Cited by 325
(1990) · PubMed · Cited by 322
Saharinen, P., & Silvennoinen, O. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205156200 · Cited by 318
JAK2, a third member of the JAK family of protein tyrosine kinases.
Harpur, A. G., Andres, A. ‐., Ziemiecki, A., Aston, R. R., & Wilks, A. F. (1992) · PubMed · Cited by 306
Self-citationTakemoto, S., Mulloy, J. C., Cereseto, A., Migone, T.-S., Patel, B. K. R., Matsuoka, M., Yamaguchi, K., Takatsuki, K., Kamihira, S., White, J. D., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13897 · Cited by 270
Lucet, I. S., Fantino, E., Styles, M., Bamert, R., Patel, O., Broughton, S. E., Walter, M., Burns, C. J., Treutlein, H., Wilks, A. F., et al. (2006) · Blood · doi:10.1182/blood-2005-06-2413 · Cited by 266
Self-citationThe Conserved Box 1 Motif of Cytokine Receptors Is Required for Association with JAK Kinases
Tanner, J. W., Chen, W., Young, R. L., Longmore, G. D., & Shaw, A. S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.12.6523 · Cited by 247
Mutation in the Jak Kinase JH2 Domain Hyperactivates Drosophila and Mammalian Jak-Stat Pathways
Luo, H., Rose, P., Barber, D., Hanratty, W. P., Lee, S., Roberts, T. M., D’Andrea, A. D., & Dearolf, C. R. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.3.1562 · Cited by 242
Photochemical preparation of a pyridone containing tetracycle: a Jak protein kinase inhibitor
Thompson, J. E., Cubbon, R. M., Cummings, R. T., Wicker, L. S., Frankshun, R., Cunningham, B. R., Cameron, P. M., Meinke, P. T., Liverton, N., Weng, Y., et al. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00106-3 · Cited by 234
Sensitization of IFN-γ Jak-STAT signaling during macrophage activation
Hu, X., Herrero, C., Li, W.-P., Antoniv, T. T., Falck-Pedersen, E., Koch, A. E., Woods, J. M., Haines, G. K., & Ivashkiv, L. B. (2002) · Nature Immunology · doi:10.1038/ni828 · Cited by 231
Autoinhibition of Jak2 Tyrosine Kinase Is Dependent on Specific Regions in Its Pseudokinase Domain
Saharinen, P., Vihinen, M., & Silvennoinen, O. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-06-0342 · Cited by 216
Jak-Stat signal transduction pathway through the eyes of cytokine class II receptor complexes
Kotenko, S. V., & Pestka, S. (2000) · Oncogene · doi:10.1038/sj.onc.1203524 · Cited by 205
Somatic Mutations of JAK1 and JAK3 in Acute Leukemias and Solid Cancers
Jeong, E. G., Kim, M. S., Nam, H. K., Min, C. K., Lee, S., Chung, Y. J., Yoo, N. J., & Lee, S. H. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4839 · Cited by 201
Lindauer, K., Loerting, T., Liedl, K. R., & Kroemer, R. T. (2001) · Protein Engineering, Design and Selection · doi:10.1093/protein/14.1.27 · Cited by 182
Crystal structure of the Jak3 kinase domain in complex with a staurosporine analog
Boggon, T. J., Li, Y., Manley, P. W., & Eck, M. J. (2005) · Blood · doi:10.1182/blood-2005-02-0707 · Cited by 170
Schindler, C., & Strehlow, I. (1999) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60111-8 · Cited by 166
JAK1 and Tyk2 Activation by the Homologous Polycythemia Vera JAK2 V617F Mutation
Staerk, J., Kallin, A., Demoulin, J.-B., Vainchenker, W., & Constantinescu, S. N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500358200 · Cited by 163
Chen, M., Cheng, A., Candotti, F., Zhou, Y.-J., Hymel, A., Fasth, A. L., Notarangelo, L. D., & O’Shea, J. J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.3.947-956.2000 · Cited by 152
James, C., Ugo, V., Casadevall, N., Constantinescu, S. N., & Vainchenker, W. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.10.003 · Cited by 150
JAK3: a novel JAK kinase associated with terminal differentiation of hematopoietic cells.
Rane, S. G., & Reddy, E. P. (1994) · PubMed · Cited by 148
Jiang, J., Ghoreschi, K., Deflorian, F., Chen, Z. J., Perreira, M., Pesu, M., Smith, J. A., Nguyễn, Ð.-T., Liu, E. H., Leister, W., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm801142b · Cited by 131
Girault, J., Labesse, G., Mornon, J., & Callebaut, I. (1998) · Molecular Medicine · doi:10.1007/bf03401769 · Cited by 114
Identification of somatic JAK1 mutations in patients with acute myeloid leukemia
Xiang, Z., Zhao, Y., Mitaksov, V., Fremont, D. H., Kasai, Y., Molitoris, A., Ries, R. E., Miner, T. L., McLellan, M. D., DiPersio, J. F., et al. (2007) · Blood · doi:10.1182/blood-2007-05-090308 · Cited by 110
The JAK kinases: Not just another kinase drug discovery target
Wilks, A. F. (2008) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2008.07.020 · Cited by 97
Self-citationRadtke, S., Haan, S., Jörissen, A., Hermanns, H. M., Diefenbach, S., Smyczek, T., de Leur, H. S.-V., Heinrich, P. C., Behrmann, I., & Haan, C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500822200 · Cited by 90
Fragment-based discovery of JAK-2 inhibitors
Antonysamy, S., Hirst, G. C., Park, F., Sprengeler, P. A., Stappenbeck, F., Steensma, R. W., Wilson, M., & Wong, M. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.08.064 · Cited by 83
Cross-Talk Between IL-1 and IL-6 Signaling Pathways in Rheumatoid Arthritis Synovial Fibroblasts1
Deon, D., Ahmed, S. T., Tai, K., Scaletta, N., Herrero, C., Lee, I.-H., Krause, A., & Ivashkiv, L. (2001) · Journal of Immunology · doi:10.4049/jimmunol.167.9.5395 · Cited by 69
Haan, S., Margue, C., Engrand, A., Rolvering, C., de Leur, H. S.-V., Heinrich, P. C., Behrmann, I., & Haan, C. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.2.998 · Cited by 63
Manshouri, T., Quintás‐Cardama, A., Nussenzveig, R. H., Gaikwad, A. S., Estrov, Z. E., Prchal, J. T., Cortes, J. E., Kantarjian, H. M., & Verstovšek, S. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00817.x · Cited by 62
Computational and functional analysis of the putative SH2 domain in Janus Kinases.
Kampa, D., & Burnside, J. (2000) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1006/bbrc.2000.3757 · Cited by 56
JAKing up hematopoietic proliferation
Shannon, K., & Etten, R. A. V. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.002 · Cited by 38
Structure and function of the protein tyrosine kinases
Wilks, A. F. (1990) · Progress in Growth Factor Research · doi:10.1016/0955-2235(90)90026-g · Cited by 22
Self-citation
Cited by
FDA-approved small-molecule kinase inhibitors
Wu, P., Nielsen, T. E., & Clausen, M. H. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.04.005 · Cited by 1,013
The molecular details of cytokine signaling via the JAK/STAT pathway
Morris, R., Kershaw, N. J., & Babon, J. J. (2018) · Protein Science · doi:10.1002/pro.3519 · Cited by 943
Roskoski, R. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2015.10.021 · Cited by 886
Interleukin-6: designing specific therapeutics for a complex cytokine
Garbers, C., Heink, S., Korn, T., & Rose-John, S. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.45 · Cited by 643
Clark, J. D., Flanagan, M. E., & Telliez, J.-B. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401490p · Cited by 601
Metadata
- Authors
- Williams, N. K., Bamert, R. S., Patel, O., Wang, C., Walden, P. M., Wilks, A. F., Fantino, E., Rossjohn, J., & Lucet, I. S.
- Venue
- Journal of Molecular Biology
- Publisher
- Elsevier BV
- Published
- 2009-03
- Volume
- 387
- Issue
- 1
- Pages
- 219-232
- ISSN
- 0022-2836 (ISSN-L)
- OpenAlex
- W2031060692
- Cited by
- 270
- References
- 46
- FWCI
- 7.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.